View our masking and visitation guidelines based on current rates of respiratory illnesses in the community.

Our new building on the hospital campus, Forest B, is open. Families and visitors can park in the new Forest B garage next to Emergency.

Clinical Trial Search block Test

Fontan Udenafil Exercise Longitudinal Assessment Trial (FUEL-2 Study)

FUEL-2

Phase: III
Clinicaltrials.gov ID: NCT05918211

What is the goal of the study?

To evaluate the clinical efficacy and safety of udenafil, an orally administered, potent and selective inhibitor of phosphodiesterase type 5 (PDE5), versus placebo for the treatment of adolescent subjects who have undergone the Fontan procedure.

Who can participate in the study?

Everyone

Study Team:

PI (Study Doctor): Matthew Files
Study Team Member: Ranjini Prakash, ranjini.prakash@seattlechildrens.org